Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

New self-referencing glutamate biosensor to measure glutamate flux of neural cells in living organism

A new biosensor developed at Purdue University can measure whether neurons are performing correctly when communicating with each other, giving researchers a tool to test the effectiveness of new epilepsy or seizure treatments.

21 Apr 2010

Florida House approves expanding Medicaid managed care; Kansas weighs proposal to raise nursing home fees

Calling the current system 'broken' and warning of long-term financial problems, the state House today approved a proposal that would gradually shift almost all Medicaid recipients into managed-care plans. The votes on two bills set the stage for the House and Senate to try to reach agreement on a Medicaid overhaul before the annual legislative session ends April 30.

21 Apr 2010

Teva Pharmaceutical Industries presents ADAGIO study results at AAN Annual Meeting

Teva Pharmaceutical Industries Ltd. today announced results from the placebo group analyses of the ADAGIO study that were presented at the 62nd Annual Meeting of the American Academy of Neurology. The ADAGIO study stands out from other Parkinson's disease trials as it is the largest clinical study conducted in patients who were still in the very early stages of their disease course (average time from PD diagnosis of 4.5 months).

20 Apr 2010

Basal ganglia and cerebellum linked together to form integrated functional network: Researchers

Researchers at the University of Pittsburgh have found new evidence that the basal ganglia and the cerebellum, two important areas in the central nervous system, are linked together to form an integrated functional network. The findings are available online this week in the Proceedings of the National Academy of Sciences.

20 Apr 2010

New technique that involves voice analysis to diagnose Parkinson's disease developed

A new technique assisting in early diagnosis of Parkinson's disease has been developed by Prof. Shimon Sapir of the Department of Communication Sciences and Disorders at the University of Haifa. This technique involves analysis of voice and articulation. The research was carried out alongside U.S. scientists and with funding from the National Institutes of Health, and results have been published in the Journal of Speech, Language, and Hearing Research.

20 Apr 2010

Study identifies protective relationship between gene variant and cognitive function in older people

New research shows a gene variant may help protect the memory and thinking skills of older people. The research will be published in the April 20, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.

20 Apr 2010

Potential drug to annul ADAM-17 protein activity needed

Over the past four years, in the installations of the Faculty of Medicine, University of Cadiz, a group of researchers, headed by Doctor Carmen Estrada, has been studying neurogenesis - the process of forming new neurons from mother cells - in the adult mammal brain. The purpose of this research project is to contribute to the knowledge of this process with the object of finding some additional mechanism that would facilitate the treatment of pathologies of the central nervous system (CNS) that are suffered in consequence of neuronal death.

19 Apr 2010

President of Tanzania emphasizes on health care in Global Health Grand Rounds lecture

President Jakaya Kikwete of the United Republic of Tanzania spoke at Weill Cornell Medical College today. In his Global Health Grand Rounds lecture, President Kikwete discussed the most significant challenges facing Tanzania, with a particular focus on health care and the advances made during his first term.

17 Apr 2010

700 scientists to present new information on smell and taste at AChemS 32nd annual meeting

The Association for Chemoreception Sciences (AChemS), a US-based scientific organization, is holding its 32nd annual meeting. About 700 scientists are gathering to present new information on the role of smell and taste in disease, nutrition and social interactions in humans as well as animals. Smell and taste play essential roles in our daily lives. These chemical senses serve as important warning systems, alerting us to the presence of potentially harmful situations or substances, including gas leaks, smoke, and spoiled food.

17 Apr 2010

Access to NAbs testing important for MS therapy management

Teva Neuroscience today announced results at the 62nd American Academy of Neurology Annual Meeting which demonstrated that eliminating barriers to neutralizing antibodies (NAbs) testing significantly impacted multiple sclerosis (MS) treatment choices in patients receiving interferon beta (IFNβ) therapies.

17 Apr 2010

Researchers receive honorary Doctor of Medicine degrees

Two genetics researchers from the Johns Hopkins University School of Medicine have been awarded prestigious honorary Doctor of Medicine degrees by European scientific institutions.

17 Apr 2010

New long-term care insurance will provide flexible cash benefits

Writing for Kaiser Health News, Harris Meyer explains the CLASS Act, which is a part of the new health reform law: "Millie Toda of Toledo, Ohio, takes cares of her husband Richard, 83, who is severely disabled from Parkinson's Disease.

16 Apr 2010

Enrollment completed in Impax Pharmaceuticals' APEX-PD trial of IPX066

Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc., today announced that it has completed enrollment of its APEX-PD trial. APEX-PD is a multinational Phase III trial of its late-stage drug candidate IPX066 in subjects with early Parkinson's disease.

16 Apr 2010

High sensitivity of Zetasizer Nano proves essential for protein aggregation studies

Dr Martin Muschol, Assistant Professor at the University of South Florida’s (USF) Department of Physics and his team are carrying out important research to gain a better understanding of protein aggregation phenomena, including protein crystallization and amyloid fibril growth. Using the Zetasizer Nano ZS, from Malvern Panalytical (Malvern Panalytical, UK), the USF researchers have been able to perform temperature controlled static and dynamic light scattering (DLS) measurements of protein hydration, protein interactions and aggregation kinetics in vitro.

From Malvern Panalytical 15 Apr 2010

First Edition: April 15, 2010

In today's headlines: The jobless benefits package, including a COBRA subsidy extension and Medicare-doctor pay fix, advances in the Senate. In the House, a committee chairman cancels a hearing on business health care complaints.

15 Apr 2010

EU Joint Programming initiative to tackle neurodegenerative diseases

Leading researchers from across Europe will gather today in Stockholm to develop a European-wide research strategy to tackle neurodegenerative diseases such as Alzheimer's and Parkinson's Disease.

15 Apr 2010

New investigational treatment may help prevent involuntary outbursts in MS and ALS patients

Pseudobulbar affect (PBA) is a neurologic condition of involuntary, sudden and frequent episodes of laughing or crying and is quite common in patients with underlying neurologic diseases or injuries, especially those with multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS).

15 Apr 2010

GBS cases reduce following 2009 H1N1 vaccination: Research study

A new study finds that reports of a neurologic disease called Guillain-Barré syndrome have been low after 2009 H1N1 vaccination, according to a research study that will be presented as part of the late-breaking science program at the American Academy of Neurology's 62nd Annual Meeting in Toronto, April 10 - 17, 2010.

15 Apr 2010

Patients with RLS using rotigotine achieve sustained improvements

New data presented at the 62nd American Academy of Neurology annual meeting in Toronto, Canada, showed that patients with moderate to severe Restless Legs Syndrome using rotigotine achieved sustained improvements in symptoms over 5 years of treatment.

15 Apr 2010

Rexahn Pharmaceuticals' Phase IIa clinical results of Serdaxin for MDD: Additional insights

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system (CNS) therapeutics, today offered additional commentary, clarifications and insights on yesterday's announcement of its Phase IIa clinical results of Serdaxin® in the treatment of major depressive disorder (MDD).

15 Apr 2010

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

New self-referencing glutamate biosensor to measure glutamate flux of neural cells in living organism

Florida House approves expanding Medicaid managed care; Kansas weighs proposal to raise nursing home fees

Teva Pharmaceutical Industries presents ADAGIO study results at AAN Annual Meeting

Basal ganglia and cerebellum linked together to form integrated functional network: Researchers

New technique that involves voice analysis to diagnose Parkinson's disease developed

Study identifies protective relationship between gene variant and cognitive function in older people

Potential drug to annul ADAM-17 protein activity needed

President of Tanzania emphasizes on health care in Global Health Grand Rounds lecture

700 scientists to present new information on smell and taste at AChemS 32nd annual meeting

Access to NAbs testing important for MS therapy management

Researchers receive honorary Doctor of Medicine degrees

New long-term care insurance will provide flexible cash benefits

Enrollment completed in Impax Pharmaceuticals' APEX-PD trial of IPX066

High sensitivity of Zetasizer Nano proves essential for protein aggregation studies

First Edition: April 15, 2010

EU Joint Programming initiative to tackle neurodegenerative diseases

New investigational treatment may help prevent involuntary outbursts in MS and ALS patients

GBS cases reduce following 2009 H1N1 vaccination: Research study

Patients with RLS using rotigotine achieve sustained improvements

Rexahn Pharmaceuticals' Phase IIa clinical results of Serdaxin for MDD: Additional insights

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in